Haisen Pharmaceutical: Net profit in 2025 is 136 million yuan, a year-on-year increase of 10.87%.

Haisen Pharmaceuticals announced that its operating revenue in 2025 was 532 million yuan, a year-on-year increase of 12.88%; net profit was 136 million yuan, a year-on-year increase of 10.87%. The profit distribution plan approved by the board of directors is: based on the total share capital on the record date of the equity distribution for the year 2025, a cash dividend of 1.16 yuan will be distributed to all shareholders for every 10 shares, with no bonus shares issued and no conversion of reserves into share capital.